Novo Nordisk A/S (NONOF)
OTC
Real-time Data
01:30 PM
Day's Range
46.3852 wk Range
34.00Overview - NONOF - Novo Nordisk A/S
Key Statistics
Valuation
Enterprise Value
47.23B
P/E (Trailing)
‪11.41‬
PEG Ratio
‪-0.55‬
Price / Sales (TTM)
‪0.62‬
Price / Book
‪6.04‬
EV / EBITDA
‪1.74‬
Profitability
Gross Margin
‪78.21%‬
Profit Margin
‪35.34%‬
Operating Margin
‪42.54%‬
Return on Assets
‪18.72%‬
Return on Equity
‪59.81%‬
Ownership
Shares Outstanding
4.42B
Float
3.17B
Held by Insiders
‪5.28%‬
Held by Institutions
‪33.32%‬
Price stats
Beta
‪0.34‬
50-Day Avg
‪47.27‬
200-Day Avg
‪46.19‬
Dividends
Payout Ratio
‪44.57%‬
Frequency
Semi-Annual
Analyst Consensus
1 analysts
Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - NONOF - Novo Nordisk A/S
Peers - NONOF - Novo Nordisk A/S
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on OTC.
- NONOFOTCNovo Nordisk A/S206.51BMarket Cap-22.13%52-week change11.50P/E (Trailing)‪35.34%‬Profit Margin
- RHHVFOTCRoche Holding AG372.60BMarket Cap+32.02%52-week change24.39P/E (Trailing)‪19.60%‬Profit Margin
- NVNVSEFOTCNovartis AG299.57BMarket Cap+22.65%52-week change23.81P/E (Trailing)‪22.50%‬Profit Margin
- GLAXFOTCGSK plc101.54BMarket Cap+21.96%52-week change15.94P/E (Trailing)‪14.52%‬Profit Margin
- CHGCYOTCChugai Pharmaceutical Co. Ltd.73.03BMarket Cap+4.25%52-week change23.88P/E (Trailing)‪35.10%‬Profit Margin
- BAYZFOTCBayer AG55.43BMarket Cap+41.82%52-week change28.11P/E (Trailing)‪-3.83%‬Profit Margin
- BAYRYOTCBayer AG Sponsored ADR55.13BMarket Cap+42.18%52-week change28.38P/E (Trailing)‪-3.83%‬Profit Margin
Profile Summary - NONOF - Novo Nordisk A/S
About
Novo Nordisk A/S is a global pharmaceutical company specializing in research, development, and manufacturing of treatments for serious chronic diseases. Founded through the 1989 merger of Danish insulin pioneers Nordisk Insulaboratorium and Novo Terapeutisk Laboratorium, it traces its roots to 1923 when commercial…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
